After weeks of anticipation, President Donald Trump unveiled a new set of tariffs on both allies and adversaries, aiming to address what he describes as unfair trade practices. The tariffs, which are set to impact countries that impose high duties on US exports,

India, China, and the European Union, which produce the vast majority of active pharmaceutical ingredients (APIs) used in drugs and also manufactured finished products, will face reciprocal tariffs from the United States,

Ahead of the rollout of US President Donald Trump’s reciprocal tariffs, China has reached out to fellow Asian countries in an apparent bid to create partnerships to minimise the fallout from tariffs